Mid-Ohio Behavioral Health

Mid-Ohio Behavioral Health brings Spravato treatment to Coshocton for adults with treatment-resistant depression. This esketamine nasal spray is administered in the office, where patients are observed for two hours after each session in line with safety requirements.

Spravato targets the NMDA receptor and glutamate rather than the pathways addressed by conventional antidepressants, which allows it to ease symptoms more rapidly. Providers tailor the dosing schedule to each patient and review therapeutic benefit throughout treatment.

The Coshocton office also delivers TMS therapy, psychiatric care, medication management, and counseling, with a sliding-scale option based on family size and income. The team focuses on personalized treatment aimed at restoring a healthier, more productive life.